Rapidly progressive glomerulonephritis superimposed on diabetic glomerulosclerosis. Recognition and treatment.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 7057537)

Published in JAMA on March 12, 1982

Authors

S A Carstens, L A Hebert, J C Garancis, W F Piering, J Lemann

Articles by these authors

Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med (1995) 5.50

Primate erythrocyte-immune complex-clearing mechanism. J Clin Invest (1983) 3.57

Thiazide diuretic monotherapy for hypertension: diuretic's dark side just got darker. Kidney Int (2007) 2.84

A simple method of estimating progression of chronic renal failure. Lancet (1976) 2.72

Synovial fluid lymphocytes differ from peripheral blood lymphocytes in patients with rheumatoid arthritis. J Immunol (1982) 2.22

Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial. Kidney Int (2001) 2.17

A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Kidney Int (1999) 1.82

Studies of the mechanism by which phosphate infusion lowers serum calcium concentration. J Clin Invest (1966) 1.81

The living donor in kidney transplantation. Ann Intern Med (1987) 1.81

The effects of chronic acid loads in normal man: further evidence for the participation of bone mineral in the defense against chronic metabolic acidosis. J Clin Invest (1966) 1.80

Interaction of rifampin and glucocorticoids. Adverse effect on renal allograft function. JAMA (1976) 1.77

Defense of hydrogen ion concentration in chronic metabolic acidosis. A new evaluation of an old approach. Ann Intern Med (1966) 1.70

Serum C3 levels are diagnostically more sensitive and specific for systemic lupus erythematosus activity than are serum C4 levels. The Lupus Nephritis Collaborative Study Group. Am J Kidney Dis (1991) 1.66

Use of monoclonal antibodies to analyze peripheral blood and salivary gland lymphocyte subsets in Sjögren's syndrome. Arthritis Rheum (1982) 1.58

The effects of diet and stool composition on the net external acid balance of normal subjects. J Clin Invest (1966) 1.49

Complement depletion accelerates the clearance of immune complexes from the circulation of primates. J Clin Invest (1984) 1.46

Effects of enteric neural defunctioning on small bowel motility. Am J Physiol (1990) 1.40

Renoprotective therapy: how good can it get? Kidney Int (2000) 1.39

Therapy of membranous nephropathy: what to do after the after (meta) analyses. J Am Soc Nephrol (1995) 1.39

The effect of glucose on urinary cation excretion during chronic extracellular volume expansion in normal man. J Clin Invest (1974) 1.35

Possible role of carbohydrate-induced calciuria in calcium oxalate kidney-stone formation. N Engl J Med (1969) 1.32

"Milwaukee shoulder"--association of microspheroids containing hydroxyapatite crystals, active collagenase, ad neutral protease with rotator cuff defects. III. Morphologic and biochemical studies of an excised synovium showing chondromatosis. Arthritis Rheum (1981) 1.31

The importance of phosphate in regulating plasma 1,25-(OH)2-vitamin D levels in humans: studies in healthy subjects in calcium-stone formers and in patients with primary hyperparathyroidism. J Clin Endocrinol Metab (1977) 1.30

CR1 and CR1-like: the primate immune adherence receptors. Immunol Rev (2001) 1.27

Calcium and phosphate metabolism in tumoral calcinosis. Ann Intern Med (1980) 1.22

The complex nature of serum C3 and C4 as biomarkers of lupus renal flare. Lupus (2010) 1.21

Histopathologic changes in snoring and obstructive sleep apnea syndrome. Laryngoscope (1991) 1.20

Spot urine protein/creatinine ratios are unreliable estimates of 24 h proteinuria in most systemic lupus erythematosus nephritis flares. Kidney Int (2007) 1.18

The effect of treatment of acidosis on calcium balance in patients with chronic azotemic renal disease. J Clin Invest (1967) 1.17

Renal artery dissection causing renal infarction in otherwise healthy men. Am J Kidney Dis (1997) 1.17

Studies in experimental staphylococcal endocarditis in dogs. V. Treatment with oxacillin. J Lab Clin Med (1967) 1.17

The transtubular potassium concentration in patients with hypokalemia and hyperkalemia. Am J Kidney Dis (1990) 1.17

Urinary excretion of 25-hydroxyvitamin D in health and the nephrotic syndrome. J Lab Clin Med (1982) 1.16

Immune-complex disease in guinea pig lungs. I. Elicitation by aerosol challenge, suppression with cobra venom factor, and passive transfer with serum. Clin Immunol Immunopathol (1977) 1.16

Evidence that glucose ingestion inhibits net renal tubular reabsorption of calcium and magnesium in man. J Lab Clin Med (1970) 1.14

Lung biopsies of pigeon breeders' disease. Arch Pathol (1969) 1.12

Differential binding of immunoglobulin A and immunoglobulin G1 immune complexes to primate erythrocytes in vivo. Immunoglobulin A immune complexes bind less well to erythrocytes and are preferentially deposited in glomeruli. J Clin Invest (1986) 1.11

Granular cell myoblastoma. Cancer (1970) 1.10

5/6 nephrectomy as a validated rat model mimicking human warfarin-related nephropathy. Am J Nephrol (2012) 1.10

Dietary phosphate deprivation in women and men: effects on mineral and acid balances, parathyroid hormone and the metabolism of 25-OH-vitamin D. J Clin Endocrinol Metab (1976) 1.10

Metabolism and excretion of 3H-1,25-(OH)2-vitamin D3 in healthy adults. J Clin Endocrinol Metab (1978) 1.10

Significance of cytoplasmic microtubules in lupus nephritis. Am J Pathol (1971) 1.08

Bone resorption stimulated by elevated serum 1,25-(OH)2-vitamin D concentrations in healthy men. Kidney Int (1983) 1.08

A potential error in the measurement of urinary titratable acid. J Lab Clin Med (1966) 1.07

The erythrocyte-immune complex-glomerulonephritis connection in man. Kidney Int (1987) 1.07

Some hemodynamic determinants of immune complex trapping by the kidney. Kidney Int (1978) 1.05

Clearance of human antibody/DNA immune complexes and free DNA from the circulation of the nonhuman primate. Clin Immunol Immunopathol (1987) 1.04

Phenotypes, genotypes and disease susceptibility associated with gene copy number variations: complement C4 CNVs in European American healthy subjects and those with systemic lupus erythematosus. Cytogenet Genome Res (2009) 1.03

The metabolism of vitamin D3 and 25-hydroxyvitamin D3 in normal and anephric humans. J Clin Endocrinol Metab (1974) 1.03

Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril Study. Am J Kidney Dis (1999) 1.02

The effects of oral CaCO3 loading and dietary calcium deprivation on plasma 1,25-dihydroxyvitamin D concentrations in healthy adults. J Clin Endocrinol Metab (1979) 1.01

Plasma 1,25-(OH)2-vitamin D concentrations and net intestinal calcium, phosphate, and magnesium absorption in humans. Am J Clin Nutr (1979) 0.99

Effects of calcitriol administration on calcium metabolism healthy men. Kidney Int (1982) 0.98

The lack of effect of chronic metabolic acidosis on 25-OH-vitamin D metabolism and serum parathyroid hormone in humans. J Clin Endocrinol Metab (1976) 0.98

Type II glycogenosis. Biochemical and electron microscopic study. Am J Med (1968) 0.98

Diagnostic significance of hypocomplementemia. Kidney Int (1991) 0.97

Interactions between precipitating and nonprecipitating antibodies in the formation of immune complexes. J Immunol (1987) 0.97

A comparison of the effects of glucose ingestion and NH4Cl acidosis on urinary calcium and magnesium excretion in man. J Clin Invest (1970) 0.97

Measurement of the fractional uptake of macromolecules by the renal vascular bed compared to other vascular beds. J Lab Clin Med (1976) 0.97

The effect of a potassium-deficient diet on the pattern of recovery from experimental metabolic acidosis. Clin Sci (1968) 0.96

Proteinuria in health and disease assessed by measuring the urinary protein/creatinine ratio. Clin Chem (1987) 0.96

Evaluation of the mechanisms responsible for the reduction in erythrocyte complement receptors when immune complexes form in vivo in primates. J Immunol (1990) 0.95

End-stage renal disease (ESRD)after bone marrow transplantation: poor survival compar ed to other causes of ESRD. Nephron (1998) 0.94

Sodium sulfate infusions and hypercalcemia. JAMA (1965) 0.94

The importance of renal net acid excretion as a determinant of fasting urinary calcium excretion. Kidney Int (1986) 0.93

Mycophenolate mofetil therapy in lupus nephritis: clinical observations. J Am Soc Nephrol (1999) 0.93

Consumption of erythrocyte CR1 (CD35) is associated with protection against systemic lupus erythematosus renal flare. Clin Exp Immunol (2006) 0.92

Mannosyl transfer in Cryptococcus laurentii. J Biol Chem (1970) 0.92

Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q. Lupus (2011) 0.92

Competitive enzyme-liked immunoassay with use of soluble enzyme/antibody immune complexes for labeling. I. Measurement of human choriogonadotropin. Clin Chem (1976) 0.92

Diffuse sclerotic skeletal metastases as an initial feature of gastric carcinoma. Arch Intern Med (1980) 0.92

Subacute bacterial endocarditis masquerading as type III essential mixed cryoglobulinemia. J Am Soc Nephrol (1997) 0.91

Ketoconazole reduces elevated serum levels of 1,25-dihydroxyvitamin D in hypercalcemic sarcoidosis. J Endocrinol Invest (1990) 0.91

Phosphate deprivation increases serum 1,25-(OH)2-vitamin D concentrations in healthy men. Kidney Int (1984) 0.91

Varieties of growing skull fractures in childhood. J Neurosurg (1970) 0.90

Measurement of SC5b-9 in urine in patients with the nephrotic syndrome. Kidney Int (1991) 0.90

Factors influencing the binding of large immune complexes to the primate erythrocyte CR1 receptor. Clin Immunol Immunopathol (1984) 0.90

Hepatic adenoma. Biochemical and electron microscopic study. Cancer (1969) 0.89

Studies of the acute effects of aldosterone and cortisol on the interrelationship between renal sodium, calcium and magnesium excretion in normal man. Nephron (1970) 0.89

Calcium-oxalate-crystal-induced bone disease. Am J Kidney Dis (1982) 0.88

Ultrastructure and hormone synthesis of choriocarcinoma in vitro. Am J Pathol (1969) 0.88

Progressive multifocal leukoencephalopathy and malignant lymphoma of the brain in a patient with immunosuppressive therapy. Acta Neuropathol (1980) 0.86

The simultaneous measurement of vitamin D metabolites in plasma: studies in healthy adults and in patients with calcium nephrolithiasis. J Lab Clin Med (1978) 0.86

Ureteral stenosis due to recurrent Wegener's granulomatosis after kidney transplantation. J Am Soc Nephrol (1994) 0.85

Evidence that abnormally large seasonal declines in vitamin D status may trigger SLE flare in non-African Americans. Lupus (2012) 0.85

Establishing the diagnosis of benign familial hematuria. The importance of examining the urine sediment of family members. JAMA (1988) 0.85

Immune complexes bind preferentially to specific subpopulations of human erythrocytes. Clin Immunol Immunopathol (1990) 0.85

Type 3 glycogenosis. A biochemical and electron microscopic study. Lab Invest (1970) 0.85

Urinary calcium excretion in human beings. N Engl J Med (1979) 0.84

Immune complex erythrocyte complement receptor interactions in vivo during induction of glomerulonephritis in nonhuman primates. J Lab Clin Med (1990) 0.84

Regulation of pH in rat papillary tubule cells in primary culture. J Clin Invest (1987) 0.84

The ultrastructure of apocrine cells in intracystic papilloma and fibrocystic disease of the breast. Arch Pathol (1970) 0.84

Clinical heterogeneity and treatment response in inclusion body myositis. Arthritis Rheum (1989) 0.83

Calcitriol, calcium, and granulomatous disease. N Engl J Med (1984) 0.83